Tyra biosciences to participate at 2023 cantor global healthcare conference

Carlsbad, calif. , sept. 12, 2023 /prnewswire/ -- tyra biosciences, inc. (nasdaq: tyra), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in fibroblast growth factor receptor (fgfr) biology, today announced that management will participate at the 2023 cantor global healthcare conference, taking place september 26-28, 2023, in new york, ny.
TYRA Ratings Summary
TYRA Quant Ranking